Cognition Therapeutics, Inc. (CGTX)

Cognition Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	29.92	41.56	54.72	5.19	2.89
Cash & Cash Equivalents	29.92	41.56	54.72	5.19	2.89
Cash Growth	-28.01%	-24.05%	954.56%	79.55%	-
Receivables	0	0	0.47	0.59	1.46
Other Current Assets	4.3	6.09	3.8	1.13	2.81
Total Current Assets	34.22	47.65	58.99	6.91	7.16
Property, Plant & Equipment	0.94	1.05	0.15	0.21	0.3
Other Long-Term Assets	0	1.73	0	0	0
Total Long-Term Assets	0.94	2.78	0.15	0.21	0.3
Total Assets	35.16	50.43	59.14	7.12	7.46
Accounts Payable	3.7	3.22	4.17	2	2.36
Deferred Revenue	1.7	3.39	0.75	0	0
Current Debt	0.17	0.15	0	0	0
Other Current Liabilities	4.6	1.04	2.94	1.25	1.32
Total Current Liabilities	10.17	7.8	7.86	3.25	3.68
Long-Term Debt	0.52	0.7	0	12.85	6.9
Other Long-Term Liabilities	0	1.69	0	3.83	2.37
Total Long-Term Liabilities	0.52	2.38	0	16.68	9.27
Total Liabilities	10.69	10.18	7.86	19.93	12.95
Total Debt	0.69	0.84	0	12.85	6.9
Debt Growth	-17.77%	-	-	86.23%	-
Retained Earnings	-141.19	-115.4	-94	-68.22	-58.24
Comprehensive Income	-0.2	-0.2	-0.2	-0.19	-0.19
Shareholders' Equity	24.47	40.25	51.27	-68.18	-58.42
Net Cash / Debt	29.23	40.72	54.72	-7.66	-4.01
Net Cash / Debt Growth	-28.22%	-25.59%	-	-	-
Net Cash Per Share	0.97	1.72	10.54	-15.08	-2.64
Working Capital	24.05	39.85	51.13	3.66	3.48
Book Value Per Share	0.81	1.70	9.88	-134.19	-38.45

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).